NATERA INC (Common Stock) – ticker 45E (NTRA)
Natera Inc. (NTRA) is currently trading at $322.10, a level that appears stretched given its negative EPS of -1.62. The company has demonstrated impressive revenue growth of 38.8%, but this is overshadowed by significant insider selling totaling $383.8 million against zero purchases, leading to a heavy insider selling verdict. Technically, the stock is exhibiting extreme overbought conditions with an RSI of 76.14 and a Stochastic reading of 98.79, suggesting a high probability of a pullback.
While the strong revenue growth is a positive fundamental indicator for Natera Inc. in the Diagnostics & Research industry, the confluence of negative profitability, aggressive insider divestitures, and overextended technicals presents a compelling risk-reward scenario favoring caution. Investors should monitor for any signs of trend reversal or a shift in insider sentiment.
NTRA Price Analysis
Market Metrics
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
NTRA Analysis
Natera Inc. (NTRA) is exhibiting highly overbought technical conditions. The Relative Strength Index (RSI) stands at 76.14, well above the 70 threshold, indicating the stock is in overbought territory and susceptible to a correction. Similarly, the Stochastic Oscillator at 98.79 reinforces this sentiment, suggesting extreme upward momentum that is unsustainable in the short term. The MACD at 8.20 also indicates strong bullish momentum, but in conjunction with the RSI and Stochastic, points to a potential reversal.
The stock is trading significantly above its key moving averages: the 50-day SMA ($252.56), the 200-day SMA ($223.09), and the 20-day EMA ($270.90). While this demonstrates a strong uptrend, the magnitude of the deviation, particularly from the 20-day EMA, suggests it is extended. The Commodity Channel Index (CCI) at 377.74 further confirms the extreme bullishness and potential for a reversion to the mean. Key support levels will be critical to watch should a pullback materialize.
- Monitor insider transaction filings closely for any change in selling pressure or initiation of buying activity, as this has been a strong signal for NTRA.
- Given the extreme overbought RSI (76.14) and Stochastic (98.79), consider implementing tighter stop-loss orders or reducing position size to mitigate risk from a potential pullback.
- The company's negative EPS and substantial market cap highlight the importance of tracking its progress towards profitability and managing cash burn effectively.
Insiders have sold $383.8 million in stock with no reported purchases, signaling a potential lack of confidence in future price appreciation and contributing to a heavy insider selling verdict.
Source: Insider FilingsRSI at 76.14 and Stochastic at 98.79 indicate the stock is significantly overextended, increasing the likelihood of a short-term price correction.
Source: Technical AnalysisNatera Inc. continues to demonstrate robust top-line growth of 38.8%, indicating strong market demand for its diagnostic and research services.
Source: Company FinancialsThe company's negative EPS of -1.62 highlights ongoing profitability challenges, raising concerns about the sustainability of its high market capitalization.
Source: Company FinancialsThe outlook for Natera Inc. (NTRA) in the next 6-12 months is cautious, leaning bearish in the short term. The current technical setup is highly overextended, suggesting a correction is probable. The significant insider selling further reinforces this view, indicating that those closest to the company may see limited near-term upside or increased downside risk. While the 38.8% revenue growth is a strong positive, it is currently insufficient to offset the concerns around profitability and insider sentiment.
A potential downside target could be the 50-day SMA at $252.56 or even the 200-day SMA at $223.09 if the selling pressure intensifies. Upside potential would require a significant shift in insider behavior, a clear path to profitability, or a cooling of technical overbought conditions. Without these catalysts, the stock faces headwinds that could lead to a re-evaluation of its current market valuation.
Key Statistics
| Market Cap | 46.13B |
| P/E Ratio | N/A (Negative EPS) |
| EPS (TTM) | -1.62 |
| Dividend Yield | 0.00% |
| 52 Week High | 323.01 |
| 52 Week Low | 131.81 |
Natera Inc. (NTRA) presents a challenging fundamental picture, primarily due to its negative Earnings Per Share (EPS) of -1.62, rendering its Price-to-Earnings (P/E) ratio mathematically negative and indicating a lack of profitability. Despite a robust revenue growth rate of 38.8%, the company is not yet translating this top-line expansion into bottom-line profits. This divergence suggests potential issues with cost management or pricing power within its Diagnostics & Research industry segment.
The market capitalization of over $46 billion for a loss-making entity warrants scrutiny. While strong revenue growth is a positive indicator for future potential, the current valuation appears disconnected from profitability metrics. Investors should closely examine the company's path to profitability and its ability to sustain such high growth rates to justify its current market valuation. Competitors like ILMN and DGX operate in similar spaces, and their valuation multiples may offer a comparative benchmark, though NTRA's growth rate is notably higher.
Earnings & Growth Analysis
Natera Inc. (NTRA) is currently operating with a negative EPS of -1.62, indicating a loss-making position. While specific recent earnings beats or misses are not detailed in the provided data, the persistent negative EPS suggests that the company is prioritizing growth and market expansion over immediate profitability. The strong revenue growth of 38.8% indicates healthy demand for its diagnostic and research services.
The focus for Natera Inc. will be on its ability to scale its operations efficiently to eventually achieve profitability. Investors will be looking for a clear trajectory towards positive EPS and net margins. Without this, the current high valuation, supported only by revenue growth, carries significant risk, especially if growth rates decelerate or market conditions tighten.
Key Risks
The primary risk for Natera Inc. (NTRA) is its extreme overbought technical condition, with an RSI of 76.14 and a Stochastic of 98.79, signaling a high probability of a short-term price correction. Compounding this is the significant insider selling, with $383.8 million in sales and no reported purchases, indicating a lack of confidence from management and a heavy insider selling. Furthermore, the company's negative EPS of -1.62 highlights ongoing profitability challenges despite strong revenue growth, making its current market capitalization of over $46 billion appear stretched.
Technical Indicators
| RSI (14) | 76.14 |
| MACD | 8.20 |
| SMA 50 | 252.56 |
| SMA 200 | 223.09 |
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
NTRA Trade Plans
Specific entry, exit, and risk management levels
🔴 SHORT ENTRY (click to switch)
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
Compare with Another Ticker
Monte Carlo Projection (10yr)
People Also Watch
Compare NTRA
NTRA Insider Trading Analysis
Source: SEC Form 4| Date | Insider | Type | Shares | Value |
|---|